DE60326382D1 - Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkung - Google Patents
Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkungInfo
- Publication number
- DE60326382D1 DE60326382D1 DE60326382T DE60326382T DE60326382D1 DE 60326382 D1 DE60326382 D1 DE 60326382D1 DE 60326382 T DE60326382 T DE 60326382T DE 60326382 T DE60326382 T DE 60326382T DE 60326382 D1 DE60326382 D1 DE 60326382D1
- Authority
- DE
- Germany
- Prior art keywords
- serum
- thiokarbonic
- acids
- reducing effect
- lipid reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000002966 serum Anatomy 0.000 title 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 239000008103 glucose Substances 0.000 title 1
- 150000002632 lipids Chemical class 0.000 title 1
- 230000001603 reducing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
- C07C53/134—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings monocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pregnancy & Childbirth (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000629A ITRM20020629A1 (it) | 2002-12-19 | 2002-12-19 | Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante. |
| PCT/IT2003/000820 WO2004056355A1 (en) | 2002-12-19 | 2003-12-16 | USE OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXYCARBOXYLIC ACIDS WITH SERUM-GLUCOSE-LOWERING AND SERUM-LIPID-LOWERING ACTIVITY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60326382D1 true DE60326382D1 (de) | 2009-04-09 |
Family
ID=32676886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60326382T Expired - Lifetime DE60326382D1 (de) | 2002-12-19 | 2003-12-16 | Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkung |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7375124B2 (de) |
| EP (1) | EP1572180B1 (de) |
| JP (1) | JP2006512362A (de) |
| KR (1) | KR20050085222A (de) |
| CN (1) | CN100393309C (de) |
| AR (1) | AR042547A1 (de) |
| AT (1) | ATE423558T1 (de) |
| AU (1) | AU2003288546B8 (de) |
| BR (1) | BR0317359A (de) |
| CA (1) | CA2506627A1 (de) |
| DE (1) | DE60326382D1 (de) |
| DK (1) | DK1572180T3 (de) |
| ES (1) | ES2321708T3 (de) |
| HK (1) | HK1087007A1 (de) |
| IT (1) | ITRM20020629A1 (de) |
| MX (1) | MXPA05005848A (de) |
| PL (1) | PL378414A1 (de) |
| PT (1) | PT1572180E (de) |
| SI (1) | SI1572180T1 (de) |
| TW (1) | TWI308564B (de) |
| WO (1) | WO2004056355A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006045096A2 (en) * | 2004-10-20 | 2006-04-27 | Resverlogix Corp. | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| US8053440B2 (en) | 2007-02-01 | 2011-11-08 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular diseases |
| CA2711103C (en) | 2008-06-26 | 2016-08-09 | Resverlogix Corp. | Methods of preparing quinazolinone derivatives |
| BRPI0919327A2 (pt) * | 2008-09-05 | 2019-09-24 | Acucela Inc | compostos ligados a enxofre para tratar doenças e distúrbios oftálmicos |
| EP2382194B1 (de) | 2009-01-08 | 2014-03-12 | Resverlogix Corp. | Verfahren zur prävention und behandlung von herz-kreislauf-erkrankungen |
| JP5795304B2 (ja) | 2009-03-18 | 2015-10-14 | レスバーロジックス コーポレイション | 新規抗炎症剤 |
| KR101892987B1 (ko) | 2009-04-22 | 2018-08-30 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
| DK2773354T3 (da) | 2011-11-01 | 2019-08-05 | Resverlogix Corp | Oralformuleringer med øjeblikkelig frigivelse for substituerede quinazolinoner |
| WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
| WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
| AU2013365926B9 (en) | 2012-12-21 | 2019-01-17 | Zenith Epigenetics Ltd. | Novel heterocyclic compounds as bromodomain inhibitors |
| KR102662814B1 (ko) | 2015-03-13 | 2024-05-03 | 리스버로직스 코퍼레이션 | 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법 |
| CN114901641A (zh) * | 2020-02-28 | 2022-08-12 | 四川科伦博泰生物医药股份有限公司 | 芳香族化合物及其药物组合物和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB860303A (en) * | 1958-06-20 | 1961-02-01 | Ici Ltd | Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª |
| GB1121722A (en) * | 1966-03-31 | 1968-07-31 | Ici Ltd | New carboxylic acid derivatives |
| GB1422679A (en) | 1972-11-16 | 1976-01-28 | Funai Pharmaceutical Ind Ltd | Substituted phenoxy-a-methylpropionic acid derivatives and a process for producing the same |
| FR2285859A1 (fr) * | 1974-09-30 | 1976-04-23 | Lafon Labor | Phenylsulfinyl-amidines et derives |
| ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
-
2002
- 2002-12-19 IT IT000629A patent/ITRM20020629A1/it unknown
-
2003
- 2003-12-16 EP EP03780669A patent/EP1572180B1/de not_active Expired - Lifetime
- 2003-12-16 WO PCT/IT2003/000820 patent/WO2004056355A1/en active Application Filing
- 2003-12-16 CA CA002506627A patent/CA2506627A1/en not_active Abandoned
- 2003-12-16 PL PL378414A patent/PL378414A1/pl unknown
- 2003-12-16 DK DK03780669T patent/DK1572180T3/da active
- 2003-12-16 DE DE60326382T patent/DE60326382D1/de not_active Expired - Lifetime
- 2003-12-16 MX MXPA05005848A patent/MXPA05005848A/es active IP Right Grant
- 2003-12-16 KR KR1020057009770A patent/KR20050085222A/ko not_active Application Discontinuation
- 2003-12-16 AU AU2003288546A patent/AU2003288546B8/en not_active Ceased
- 2003-12-16 BR BR0317359-3A patent/BR0317359A/pt not_active IP Right Cessation
- 2003-12-16 PT PT03780669T patent/PT1572180E/pt unknown
- 2003-12-16 CN CNB200380106699XA patent/CN100393309C/zh not_active Expired - Fee Related
- 2003-12-16 US US10/539,833 patent/US7375124B2/en not_active Expired - Fee Related
- 2003-12-16 AT AT03780669T patent/ATE423558T1/de not_active IP Right Cessation
- 2003-12-16 SI SI200331556T patent/SI1572180T1/sl unknown
- 2003-12-16 ES ES03780669T patent/ES2321708T3/es not_active Expired - Lifetime
- 2003-12-16 JP JP2004561981A patent/JP2006512362A/ja active Pending
- 2003-12-18 TW TW092136024A patent/TWI308564B/zh not_active IP Right Cessation
- 2003-12-19 AR ARP030104731A patent/AR042547A1/es not_active Application Discontinuation
-
2006
- 2006-06-21 HK HK06107039.2A patent/HK1087007A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ITRM20020629A1 (it) | 2004-06-20 |
| ATE423558T1 (de) | 2009-03-15 |
| CN100393309C (zh) | 2008-06-11 |
| ES2321708T3 (es) | 2009-06-10 |
| AU2003288546B2 (en) | 2009-04-30 |
| PT1572180E (pt) | 2009-05-04 |
| DK1572180T3 (da) | 2009-06-02 |
| TW200420531A (en) | 2004-10-16 |
| WO2004056355A1 (en) | 2004-07-08 |
| US20060154979A1 (en) | 2006-07-13 |
| AR042547A1 (es) | 2005-06-22 |
| AU2003288546B8 (en) | 2009-06-11 |
| CN1728992A (zh) | 2006-02-01 |
| US7375124B2 (en) | 2008-05-20 |
| BR0317359A (pt) | 2005-11-08 |
| SI1572180T1 (sl) | 2009-06-30 |
| EP1572180A1 (de) | 2005-09-14 |
| TWI308564B (en) | 2009-04-11 |
| AU2003288546A1 (en) | 2004-07-14 |
| KR20050085222A (ko) | 2005-08-29 |
| CA2506627A1 (en) | 2004-07-08 |
| PL378414A1 (pl) | 2006-04-03 |
| EP1572180B1 (de) | 2009-02-25 |
| JP2006512362A (ja) | 2006-04-13 |
| HK1087007A1 (en) | 2006-10-06 |
| MXPA05005848A (es) | 2005-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60326382D1 (de) | Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkung | |
| DE60326874D1 (de) | Neue verwendung von erythropoietin in herzerkrankungen | |
| ATE498324T1 (de) | Verwendung von säuglingsnahrung mit reduziertem proteingehalt | |
| ATE346056T1 (de) | Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren | |
| IS8362A (is) | Hámörkuð tjáning HPV 45 L1 í gersveppi | |
| DE60121939D1 (de) | Verwendung von amino benzoesäuren in zusammensetzungen mit duftstoffen | |
| DE60330358D1 (de) | Stahlprodukt mit verringerter menge von aluminiumoxid-clustern | |
| ATE319437T1 (de) | Verwendungen von ppar-gamma-agonisten in neutrophil-verursachten erkrankungen | |
| ATE510556T1 (de) | Verwendung von erythropoietin | |
| DE60317639D1 (de) | Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren | |
| DE502004011575D1 (de) | Verwendung von Dioldimerfettsäureestern | |
| FI20021807A (fi) | Menetelmä akryyliamidin muodostumisen estämiseksi tai vähentämiseksi elintarvikkeissa | |
| DE60322027D1 (de) | Herstellung von defektfreien polyacrylamid-elektrophoresegelen in kunststoffkassetten | |
| DE602004015504D1 (de) | Von injektionspräparaten | |
| ATE439362T1 (de) | Ester in position 20 von camptothecinen | |
| DE60203923D1 (de) | Verwendung von cmc in fleischverarbeitungsprodukten | |
| DE602004010307D1 (de) | Verwendung von polysulfatiertem alginat in zellmatrix | |
| ATE423569T1 (de) | Verwendung von hitzelabilem escherichia-coli- toxin als adjuvans bei geflügel | |
| ATE405288T1 (de) | Selektion von eimeriastämmen in geflügel über extraintestinale sporozoiten | |
| DE60316792D1 (de) | Pharmazeutische verwendung von cox-2-hemmern in angiogenese-vermittelten augenerkrankungen | |
| DE10256898A8 (de) | Elektrochemischer Nachweis von Nukleinsäuren | |
| DE60012355D1 (de) | Phenyl- und pyridyl-tetrahydro-pyridine mit tnf inhibitorischer wirkung | |
| FI20031307A0 (fi) | Uusi entsyymi hiilihydraattien hyödyntämiseksi in vivo ja in vitro | |
| DE60222812D1 (de) | In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen | |
| DE60336549D1 (de) | Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |